Factor XI inhibiTion for the Prevention of Venous Thromboembolism in Patients Undergoing Total Knee Arthroplasty

Conditions: Knee Arthroplasty, Total Interventions: Drug: Enoxaparin; Drug: KN060 Low; Drug: KN060 Middle; Drug: KN060 Hight Sponsors: Suzhou Alphamab Co., Ltd. Recruiting

https://clinicaltrials.gov/study/NCT06180889

Source: ClinicalTrials.gov - December 25, 2023 Category: Research Source Type: clinical trials

More News: Lovenox | Research | Thrombosis